Gene clues unlock survival secrets in rare blood disease
NCT ID NCT02619565
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study followed 349 adults with myelodysplastic syndromes (MDS), a bone marrow disorder that raises the risk of leukemia. Researchers used DNA testing to find gene changes and see how they affected survival and treatment response. The goal was to better understand the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Assistance publique-Hôpitaux de Paris, Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.